Showing results (41-50 of 286) with videos related to

Sort By:
Pageof 29
Journal of Medical Virology|September 15, 2011
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis BLucia Taramasso, Patrizia Caligiuri, Antonio Di Biagio, et al.
Recent Patents on Anti-Infective Drug Discovery|July 18, 2014
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?Antonio Di Biagio, Roberta Prinapori, Lucia Taramasso, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 2, 2025
Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/RilpivirineLucia Taramasso, Franco Maggiolo, Daniela Valenti, et al.
Studies in Health Technology and Informatics|May 24, 2024
Tuberculosis Infection Control: Experiences and Considerations from a Web Based Tool ImplementationYlenia Murgia, Chiara Sepulcri, Lorenzo Crupi, et al.
The New Microbiologica|August 24, 2016
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergencyGiovanni Cenderello, Antonio Di Biagio, Niccolò Riccardi, et al.
The New Microbiologica|May 29, 2023
PRESTIGIO RING: "A 59-year-old HIV-1 positive, highly treatment-experienced woman failing darunavir/ ritonavir plus raltegravir"Laura Labate, Bianca Bruzzone, Vincenzo Spagnuolo, et al.
Studies in Health Technology and Informatics|May 17, 2025
From the Ligurian HIV Network to an European Framework for HIV Surveillance and ControlYlenia Murgia, Roberta Gazzarata, Monica Bonetto, et al.
Journal of Medical Virology|July 25, 2012
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovirMałgorzata Mikulska, Lucia Taramasso, Daniele Roberto Giacobbe, et al.
European Journal of Pediatrics|December 17, 2014
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 yearsSara Grignolo, Paola Tatarelli, Giulia Gustinetti, et al.
Health Science Reports|July 22, 2025
Safe Switch to an Oral Two-Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV-1: An Observational Multicenter StudyGiulia Meraviglia, Anna Sala, Francesco Bassani, et al.
Pageof 29